arrow
F

Florian Tran

University Hospital Schleswig-Holstein
H指数:30
被引数:5,836
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative Real-World Effectiveness of Anti-TNF, Ustekinumab and Vedolizumab in Crohn's Disease Over 24 Months: A Pooled Analysis From the Prospective UMBRELLA-IBD Registry in Germany

比较抗TNF、乌司奴单抗和 vedolizumab 在克罗恩病中 24 个月的真实世界有效性:来自德国前瞻性 UMBRELLA-IBD 注册研究的合并分析

2026-06-150
OA
Cross-species engraftment biases and metabolic divergence in gnotobiotic mice humanized with ulcerative colitis microbiota

跨物种移植偏倚及在接种溃疡性结肠炎微生物群的悉生小鼠中的代谢差异

2025-11-240
OAAI
Atg16l1 and Xbp1 cooperatively protect from transcription-associated mutagenesis and small intestinal carcinogenesis

Atg16l1和Xbp1协同保护免受转录相关突变和小肠致癌作用

2025-10-070
OA
Identification of shared and unique mechanisms of atopic dermatitis and ulcerative colitis by construction and computational analysis of disease maps

通过构建和计算分析疾病图谱,识别特应性皮炎和溃疡性结肠炎共享和独特的机制

2025-09-070
OAAI
987e: BIOMARKER-INFORMED THERAPY GUIDANCE IMPROVED CLINICAL OUTCOMES OF ANTI-TNF TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN A MULTI-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE CLINICAL TRIAL (GUIDE-IBD)

987e: 生物标志物指导的疗法改善了炎症性肠病患者抗-TNF治疗的临床结局,该研究在一项多中心、随机、开放标签、前瞻性临床试验(GUIDE-IBD)中进行。

2025-07-030
PRE
T and B cell responses against Epstein–Barr virus in primary sclerosing cholangitis

T和B细胞对Epstein–Barr病毒的应答在原发性硬化性胆管炎中的作用

2025-06-110
OA
Fecal metaproteomics enables functional characterization of remission in patients with inflammatory bowel disease

粪便元蛋白质组学能够实现炎症性肠病患者缓解期的功能表征

2025-06-010
OA
Distinct tryptophan metabotypes associate with disease activity, treatment escalation and future disease progression in Inflammatory Bowel Disease

炎症性肠病中不同的色氨酸代谢类型与疾病活动,治疗升级和未来疾病进展有关

2025-01-220
PRE
Protein-Energy Malnutrition Induces Microbiome-Dependent Long-Lasting Changes in Intestinal Epithelial Composition
2025-01-220
PRE